Morgan Stanley's decision to maintain an Equal-Weight rating on Ulta Beauty indicates a neutral outlook for the stock. However, the lowered price target from $535 to $520 may cause some short-term uncertainty among investors, but overall, the impact on the stock price is expected to be neutral.